Latest Ischemia Stories
MOUNTAIN VIEW, Calif., Feb. 9, 2011 /PRNewswire/ -- Concentric Medical, Inc.
MOUNTAIN VIEW, Calif., Jan.
Researchers at the Stanford University School of Medicine, in collaboration with BioParadox, Inc., have published data supporting the use of platelet-rich plasma as a promising biologic treatment for myocardial infarction (heart attack).
A new study identifies a molecule that is a critical regulator of neuron survival after ischemic brain injury.
CLEVELAND, Jan. 3, 2011 /PRNewswire/ -- Juventas Therapeutics, a clinical-stage regenerative medicine company developing novel therapies for cardiovascular disease, announces that the U.S.
MERION STATION, Pa., Dec. 8, 2010 /PRNewswire-USNewswire/ -- After a heart attack and the victim stops breathing, a process of irreversible brain damage starts to occur within 3 to 4 minutes. Or does it? While researching cardiac arrest, Jeffrey Dobkin read about a boy drowning in icy waters.
SAN DIEGO, Dec.
BAAR, Switzerland and TEL AVIV, November 22, 2010 /PRNewswire-FirstCall/ -- SCHILLER AG, a leading international manufacturer and supplier of cardiopulmonary diagnostics and BSP Biological Signal Processing Ltd., a medical device company that develops and markets innovative solutions for noninvasive cardiac diagnosis and monitoring , announced on November 8th, 2010 the signing of an agreement to jointly develop a new product line based on BSP's HyperQ(TM) technology.
Study provides evidence that a person's own stem cells may be used as a treatment for their heart disease.
When cardiac or skeletal muscle is not receiving enough oxygen to meet metabolic demands, a person will experience pain, such as angina, chest pain during a heart attack, or leg pain during a vigorous sprint.
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.